Predictive power of the components of metabolic syndrome in its development: A 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS)

European Journal of Clinical Nutrition

Volumn 64, Issue 10, 2010, Pages 1207-1214

  Heidari, Z ^a   Hosseinpanah, F ^b   Mehrabi, Y ^a   Safarkhani, M ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP III; components; IDF; metabolic syndrome; prediction

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREDICTION; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPOPROTEINEMIAS; HYPERTRIGLYCERIDEMIA; IRAN; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY, ABDOMINAL; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STATISTICS AS TOPIC; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 77957831046     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.111     Document Type: Article

References (30)

1. Alberti KG, Zimmet P (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553.
2. Alberti KG, Zimmet P, Shaw J (2005). The metabolic syndrome - a new worldwide definition. Lancet 366, 1059-1062.
3. Anisworth BE, Jacobs DR, Leon AS (1993). Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 25, 92-98.
4. Azizi F, Rahmani M, Emami H, Madjid M (2000). Tehran Lipid and Glucose Study: rational and design. CVD Prev 3, 242-247.
5. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A et al. (2002). Determinants of serum HDL-C level in Tehran urban population: Tehran Lipid and Glucose Study. Nutr Metab Cardio-vasc Dis 12, 80-89.
6. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S et al. (2006). Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 6, 158.
7. Balkau B, Charles MA (1999). Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16, 442-443.
8. Bloomgarden ZT (2003). American Association of Clinical Endo-crinologists (AACE) Consensus Conference on the insulin resis-tance syndrome. Diabetes Care 26, 933-939.
9. Boyko EJ, Leonetti DL, Bergstrom RW, Newell Morris L, Fujimoto WY (1995). Visceral adiposity, fasting plasma insulin, and blood pressure inJapanese-Americans. Diabetes Care 18, 174-181.
10. Cheung BM, Wat NM, Tam S, Thomas GN, Leung GM, Cheng CH et al. (2008). Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol (Oxf) 68, 730-737.
11. Davis M (1999). New diagnostic criteria for diabetes: are they doing what they should? Lancet 354, 610-611.
12. DeLong ER, DeLong DM, Clarke-Pearson DL (1988). Comparing the areas under two or more correlated receiver operating charac-teristic curves: a nonparametric approach. Biometrics 44, 837-845.
13. Esteghamati AR, Gouya MM, Abbasi M, Delavari AR, Alikhani S, Alaedini F et al. (2008). Prevalence ofdiabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care 1, 96-98.
14. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
15. Ford ES (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 28, 1769-1778.
16. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. Am Coll Cardiol 49, 403-414.
17. Ghassemi H, Harrison G, Mohammad K (2005). An accelerated nutrition transition in Iran. Public Health Nutr 5, 149-155.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, EcKel RH, Franklin BA et al. (2005). Diagnosis and Management of the metabolic syndrome. An American heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation 112, 2735-2752.
19. Han TS, Richmond P, Avenell A, Lean ME (1997). Waist circum-ference reduction and cardiovascular benefits during weight loss in women. Int J Obes Relat Metab Disord 21, 127-134.
20. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A (2007). Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 7, 32.
21. Janssen I, Katzmarzyk PT, Ross R (2004). Waist circumference and not body mass index explains obesity related health risk. Am J Clin Nutr 79, 379-384.
22. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA et al. (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156, 1070-1077.
23. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT (2003). Central adiposity determines prevalence of the metabolic syndrome. Obes Res 11, 1480-1487.
24. Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM et al. (2004). Insulin resistance. Atherosclerosis study predictors of the incident metabolic syndrome in adults: the insulin resistance atherosclerosis study. Diabetes Care 27, 788-793.
25. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. (1994). Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdo-minal visceral adipose tissue accumulation and related cardio-vascular risk in men and women. Am J Cardiol 73, 460-468.
26. Reaven GM, Lithell H, Landsberg L (1996). Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334, 374-381.
27. Sheikholeslam R, Mohammad A, Mohammad K, Vaseghi S (2004). Non-communicable disease risk factors in Iran. Asia Pac J Clin Nutr 13 (Suppl), S100.
28. Sheu WH, Chuang SY, Lee WJ, Tsai ST, Chou P, Chen CH et al. (2006). Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes Res Clin Pract 74, 162-168.
29. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB (2005). Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81, 555-563.
30. Zabetian A, Hadaegh F, Azizi F (2007). Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 77, 251-257.